MeVis Medical Solutions AG (ETR:M3V)
Germany
· Delayed Price · Currency is EUR 23.40
0.00 (0.00%)
Apr 29, 2026, 5:35 PM CET
ETR:M3V Income Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2020 - 2016 |
| Revenue | 16.06 | 16.97 | 17.34 | 18.76 | 16.21 | Upgrade
|
| Revenue Growth (YoY) | -5.36% | -2.14% | -7.57% | 15.71% | -5.35% | Upgrade
|
| Cost of Revenue | 11.18 | 10.54 | 10.34 | 10.17 | 9.29 | Upgrade
|
| Gross Profit | 4.88 | 6.43 | 7 | 8.59 | 6.92 | Upgrade
|
| Selling, General & Admin | 0.55 | 0.55 | 0.56 | 0.56 | 0.47 | Upgrade
|
| Other Operating Expenses | 1.87 | 1.75 | 1.48 | 1.48 | 1.31 | Upgrade
|
| Operating Expenses | 2.56 | 2.43 | 2.14 | 2.13 | 1.91 | Upgrade
|
| Operating Income | 2.32 | 4 | 4.86 | 6.47 | 5.02 | Upgrade
|
| Interest Expense | -0 | -0.02 | -0 | - | - | Upgrade
|
| Interest & Investment Income | 0.09 | 0.15 | 0.11 | - | 0.16 | Upgrade
|
| Earnings From Equity Investments | - | - | - | 0.18 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.21 | -0.5 | -1.01 | 1.23 | 0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.05 | 1.05 | 1.07 | - | - | Upgrade
|
| EBT Excluding Unusual Items | 3.26 | 4.69 | 5.03 | 7.88 | 5.24 | Upgrade
|
| Legal Settlements | - | - | - | - | -0.61 | Upgrade
|
| Other Unusual Items | 0.02 | - | - | - | - | Upgrade
|
| Pretax Income | 3.28 | 4.69 | 5.03 | 7.88 | 4.63 | Upgrade
|
| Income Tax Expense | 0.11 | 0.13 | 0.11 | 0.09 | 0.09 | Upgrade
|
| Net Income | 3.17 | 4.56 | 4.92 | 7.79 | 4.55 | Upgrade
|
| Net Income to Common | 3.17 | 4.56 | 4.92 | 7.79 | 4.55 | Upgrade
|
| Net Income Growth | -30.58% | -7.29% | -36.84% | 71.35% | -20.31% | Upgrade
|
| Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| EPS (Basic) | 1.74 | 2.51 | 2.70 | 4.28 | 2.50 | Upgrade
|
| EPS (Diluted) | 1.74 | 2.51 | 2.70 | 4.28 | 2.50 | Upgrade
|
| EPS Growth | -30.58% | -7.29% | -36.84% | 71.35% | -20.31% | Upgrade
|
| Free Cash Flow | 3.74 | 2.84 | 5.77 | 4.72 | 9.08 | Upgrade
|
| Free Cash Flow Per Share | 2.05 | 1.56 | 3.17 | 2.60 | 4.99 | Upgrade
|
| Dividend Per Share | 1.130 | 1.130 | 0.950 | - | - | Upgrade
|
| Dividend Growth | - | 18.95% | - | - | - | Upgrade
|
| Gross Margin | 30.38% | 37.91% | 40.38% | 45.80% | 42.70% | Upgrade
|
| Operating Margin | 14.44% | 23.58% | 28.05% | 34.46% | 30.94% | Upgrade
|
| Profit Margin | 19.71% | 26.87% | 28.37% | 41.52% | 28.04% | Upgrade
|
| Free Cash Flow Margin | 23.28% | 16.76% | 33.30% | 25.18% | 56.00% | Upgrade
|
| EBITDA | 2.47 | 4.13 | 4.96 | 6.56 | 5.14 | Upgrade
|
| EBITDA Margin | 15.36% | 24.36% | 28.60% | 34.96% | 31.71% | Upgrade
|
| D&A For EBITDA | 0.15 | 0.13 | 0.1 | 0.09 | 0.13 | Upgrade
|
| EBIT | 2.32 | 4 | 4.86 | 6.47 | 5.02 | Upgrade
|
| EBIT Margin | 14.44% | 23.58% | 28.05% | 34.46% | 30.94% | Upgrade
|
| Effective Tax Rate | 3.45% | 2.70% | 2.27% | 1.11% | 1.84% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.